Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Neurosci Res
2008 Oct 01;8613:2884-94. doi: 10.1002/jnr.21749.
Show Gene links
Show Anatomy links
Functional contribution of alpha3L8' to the neuronal nicotinic alpha3 receptor.
Nieves-Cintrón M
,
Caballero-Rivera D
,
Silva WI
,
Navedo MF
,
Lasalde-Dominicci JA
.
???displayArticle.abstract???
The role of position L8', located in transmembrane domain 1 of the neuronal nicotinic alpha3 subunit, was characterized by using two-electrode voltage clamp in Xenopus oocytes. Four amino acids (Ala, Ser, Phe, and Tyr) were inserted at this conserved position, and the mutant subunit was coexpressed with either wild-type beta2 or beta4 subunits. These substitutions led to significant alterations in the pharmacodynamic parameters of cholinergic agents, resulting in loss of function. Ala and Ser substitutions resulted in losses in agonist (ACh, nicotine, and DMPP) potency and intrinsic activity at both alpha3beta2 and alpha3beta4 receptors. Similarly, significant changes in antagonist potency were produced by the Ala and Ser substitutions. Phe and Tyr mutations did not alter the receptor's EC(50) for ACh or nicotine but reduced the EC(50) for DMPP at both receptors. The Phe mutation also reduced the intrinsic activity of all agonists tested at both receptors. The Tyr mutation, though, led to a decrease in intrinsic activity for all agonists at the alpha3beta2 receptor, yet resulted in no changes for DMPP, a decrease for nicotine, and an increase for ACh at the alpha3beta4 receptor. The most dramatic changes in the receptor's functional properties were produced by substitutions that introduced the largest changes in amino acid volume. Additional replacements (Gly, Thr, and Val) suggested an inverse correlation between amino acid volume at position alpha3L8' and EC(50) for alpha3beta4 nAChRs; however, alpha3beta2 nAChRs displayed a nonlinear correlation. These data demonstrate that structural alterations at position alpha3L8' could propagate to the agonist-binding site.
???displayArticle.pubmedLink???
18615639
???displayArticle.pmcLink???PMC4586081 ???displayArticle.link???J Neurosci Res ???displayArticle.grants???[+]
Akabas,
Identification of acetylcholine receptor channel-lining residues in the M1 segment of the alpha-subunit.
1995, Pubmed,
Xenbase
Akabas,
Identification of acetylcholine receptor channel-lining residues in the M1 segment of the alpha-subunit.
1995,
Pubmed
,
Xenbase
Annerén,
Megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS), an autosomal recessive disorder: clinical reports and review of the literature.
1991,
Pubmed
Bryant,
Effects of methyllycaconitine and related analogues on bovine adrenal alpha3beta4* nicotinic acetylcholine receptors.
2002,
Pubmed
Chakrapani,
Gating dynamics of the acetylcholine receptor extracellular domain.
2004,
Pubmed
Chavez-Noriega,
Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes.
1997,
Pubmed
,
Xenbase
Chothia,
Structural invariants in protein folding.
1975,
Pubmed
Engel,
Congenital myasthenic syndromes: multiple molecular targets at the neuromuscular junction.
2003,
Pubmed
Everhart,
Identification of residues that confer alpha-conotoxin-PnIA sensitivity on the alpha 3 subunit of neuronal nicotinic acetylcholine receptors.
2003,
Pubmed
,
Xenbase
Free,
Evidence for constitutive expression of bovine adrenal a3beta4* nicotinic acetylcholine receptors.
2002,
Pubmed
Harvey,
Multiple determinants of dihydro-beta-erythroidine sensitivity on rat neuronal nicotinic receptor alpha subunits.
1996,
Pubmed
,
Xenbase
Harvey,
Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor beta subunits.
1996,
Pubmed
,
Xenbase
Hogg,
Nicotinic acetylcholine receptors: from structure to brain function.
2003,
Pubmed
Karlin,
Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins.
1995,
Pubmed
Karlin,
Emerging structure of the nicotinic acetylcholine receptors.
2002,
Pubmed
Lee,
Principal pathway coupling agonist binding to channel gating in nicotinic receptors.
2005,
Pubmed
Leff,
Further concerns over Cheng-Prusoff analysis.
1993,
Pubmed
Mitra,
Structural dynamics of the M4 transmembrane segment during acetylcholine receptor gating.
2004,
Pubmed
Nai,
Relating neuronal nicotinic acetylcholine receptor subtypes defined by subunit composition and channel function.
2003,
Pubmed
Navedo,
Novel beta subunit mutation causes a slow-channel syndrome by enhancing activation and decreasing the rate of agonist dissociation.
2006,
Pubmed
,
Xenbase
Ochoa,
Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking.
2007,
Pubmed
Ortiz-Acevedo,
Tryptophan scanning mutagenesis of the gammaM4 transmembrane domain of the acetylcholine receptor from Torpedo californica.
2004,
Pubmed
,
Xenbase
Quiram,
Mutation causing congenital myasthenia reveals acetylcholine receptor beta/delta subunit interaction essential for assembly.
1999,
Pubmed
Raike,
Dominant-negative suppression of Cav2.1 currents by alpha(1)2.1 truncations requires the conserved interaction domain for beta subunits.
2007,
Pubmed
Skok,
Nicotinic acetylcholine receptors in autonomic ganglia.
2002,
Pubmed
Stafford,
Two domains of the beta subunit of neuronal nicotinic acetylcholine receptors contribute to the affinity of substance P.
1998,
Pubmed
,
Xenbase
Sutor,
Neuronal nicotinic acetylcholine receptors and autosomal dominant nocturnal frontal lobe epilepsy: a critical review.
2001,
Pubmed
Tapper,
Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization.
2004,
Pubmed
Vohra,
Focal caspase activation underlies the endplate myopathy in slow-channel syndrome.
2004,
Pubmed
Wang,
Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation.
1997,
Pubmed
Ward,
Methyllycaconitine: a selective probe for neuronal alpha-bungarotoxin binding sites.
1990,
Pubmed
Xu,
Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor.
1999,
Pubmed